Anti-mouse CD8α-InVivo

目录号：A2102         批次号: A210231

       克隆号：2.43

打印

Anti-mouse CD8α(克隆号：2.43)可与小鼠CD8α结合反应。CD8是一种穿膜糖蛋白，是T细胞受体（TCR）的协同受体。有助于后续与抗原呈递细胞的交流通讯。

抗体信息

克隆号 2.43
免疫原 Mouse CTL clone L3
配制 PBS buffer, pH 7.0
推荐同型对照 Rat IgG2b, κ
应用 In vivo CD8+ T cell depletion,WB
来源 CHO
储存条件
(自收到货起)		 Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
除菌 0.2 μM filtered
纯度 99%
蛋白浓度 7.40 mg/ml
内毒素 ＜1EU/mg

客户使用selleck产品的实验数据

Anti-mouse CD8α-InVivo在文献中得到引用

Angiotensin receptor blocker attacks armored and cold tumors and boosts immune checkpoint blockade [ Journal for ImmunoTherapy of Cancer, September 6, 2024, e009327] PubMed: 39244215
Impact of gut microbiome on radiotherapy and immunotherapy efficacy in microsatellite-stable colorectal cancer: role of propionic acid and B. fragilis [ British Journal of Cancer, October 2025, 956-969] PubMed: 40715695
Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell [ Gut Microbes, December 2023, 2249143] PubMed: 37635362
Senescent SPP1+ macrophages remodel the tumor microenvironment and promote the progression of early-stage lung adenocarcinoma featured with mixed ground glass nodule [ Mol Cancer, 2025, 24(1):298] PubMed: 41310768
LZTR1 regulates epithelial MHC-I expression via NF-κB1 to modulate CD8+ T cells activation [ Cell Discov, 2025, 11(1):84] PubMed: 41162356
TNC-targeted CAR-macrophage therapy alleviates liver fibrosis in mice [ Mil Med Res, 2025, 12(1):78] PubMed: 41214839
Silencing PCSK9 reshapes the spatiotemporal activation of STING for safe and effective cancer immunotherapy [ Nat Commun, 2025, 10.1038/s41467-025-66630-x] PubMed: 41290746
Targeting site-specific N-glycosylated B7H3 induces potent antitumor immunity [ Nat Commun, 2025, 16(1):3546] PubMed: 40229277
BET inhibitor in combination with BCG vaccine enhances antitumor efficacy and orchestrates T cell reprogramming for melanoma [ Cell Rep Med, 2025, 6(3):101995] PubMed: 40107246
Nuclear glycine decarboxylase suppresses STAT1-dependent MHC-I and promotes cancer immune evasion [ EMBO J, 2025, 10.1038/s44318-025-00557-3] PubMed: 40926122

禁止用于人体及治疗！